Siwarapornskul Funding Source: Internal working capital of the Company Share Transfer Date: 31 March 2020 Hence, according to the Company’s latest consolidated financial statement ended 31 December 2019, the total
) (1.50) 14.76% 438.69 474.69 (35.99) -8.20% เพิ่ม (ลด) TOTAL ASSETS TOTAL LIABILITIES TOTAL SHAREHOLDERS' EQUITY Statement of Financial Position For Quarter 1 Year 2020 (Million Baht) 5 | MANAGEMENT
02-634-0135 www.interpharma.co.th 4. MP Financial Statement Balance Sheet (Unit : Baht) 2017 Audited Statement 2018 Audited Statement 2019 Audited Statement Assets Current Assets Cash and cash
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
results, as follows. Statement of comprehensive income Revenue from hospital operations The Company booked revenue from hospital operations amounted to Baht 612.74 million and Baht 573.69 million for the
results, as follows. Statement of comprehensive income Revenue from hospital operations The Company booked revenue from hospital operations amounted to Baht 370.32 million and Baht 612.74 million for the
would like to explain and analyze the operating results that have changed for Quarter 3 Ending 30 November 2019 with the following details: Unit : million baht Statement of financial position for the 3
– CIS annually update to the SEC Thailand within 1 year after the effective date of the previously submitted registration statement, either Form 69 – CIS full or Form 69 – CIS annually update , as
ระหว่างนี้ ปปง.จะออกมาตรการ (policy statement) เพื่อให้สถาบันการเงินถือปฏิบัติไปพลาง ๆ ก่อน ดังนั้น สำนักงานจึงได้มีการเปลี่ยนแปลงแผนงานโดยจะออกประกาศสำนักงานและเข้าตรวจสอบบริษัทหลักทรัพย์หลังจากที่ปปง.ได้
financial statement. Q: Does information disclosure according to the Securities and Exchange Act B.E. 2535 go against auditor's ethics as specified in the Accounting Professions Act? In case there is